Managing trastuzumab-resistant breast cancer

Clin Adv Hematol Oncol. 2009 Feb;7(2):108-10.
No abstract available

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Clinical Trials as Topic
  • Drug Resistance, Neoplasm*
  • Female
  • Humans
  • Protein Kinase Inhibitors / therapeutic use
  • Receptor, ErbB-2 / drug effects
  • Receptor, ErbB-2 / metabolism
  • Trastuzumab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • ERBB2 protein, human
  • Receptor, ErbB-2
  • Trastuzumab